Fred Hutchinson Cancer Center
Clinical trials sponsored by Fred Hutchinson Cancer Center, explained in plain language.
-
New combo therapy aims to speed up treatment for blood cancer patients
Disease control Recruiting nowThis study tests whether a faster dose increase of the drug sonrotoclax, given with other medicines, is safe for people with certain blood cancers (CLL, SLL, or mantle cell lymphoma). The cancers may be new, returned, or not responding to treatment. The goal is to see if this qui…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Supercharged immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a personalized cell therapy for people with metastatic solid tumors that carry a specific genetic mutation (KRAS G12V). Patients' own immune cells are genetically modified to recognize and attack cancer cells. The study aims to find the safest dose an…
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New stem cell approach offers hope for blood cancer patients
Disease control Recruiting nowThis study is for people with certain blood cancers, like leukemia or lymphoma. It tests a stem cell transplant from a half-matched donor, using a special drug combo (treosulfan and fludarabine) plus low-dose radiation to prepare the body. The goal is to see if this approach help…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Could less be more? new trial aims to cut drug side effects in myeloma
Disease control Recruiting nowThis study tests whether reducing the dose of the drug linvoseltamab after an initial good response can keep multiple myeloma under control while causing fewer side effects. About 30 adults with myeloma that has returned or stopped responding to other treatments will take part. R…
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Radioactive antibody targets leukemia before transplant
Disease control Recruiting nowThis study tests a radioactive antibody (211At-BC8-B10) given before a donor stem cell transplant for people with high-risk acute leukemias or myelodysplastic syndrome. The antibody seeks out and delivers radiation to cancer cells while sparing healthy cells. The goal is to find …
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Toothbrush vs. transplant complication: can a simple cleaning prevent a deadly side effect?
Prevention Recruiting nowThis study tests whether a dental cleaning shortly after a stem cell transplant can prevent chronic graft-versus-host disease (GVHD), a serious condition where donor cells attack the patient's body. About 45 adults receiving a stem cell transplant for blood cancer will get a post…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated May 14, 2026 12:06 UTC
-
Could fiber be the secret to better stem cell transplant recovery?
Knowledge-focused Recruiting nowThis study looks at whether adding fiber supplements to the diet is possible for patients receiving donor stem cell transplants for blood cancers. The goal is to see if fiber can improve nutrition, support healthy gut bacteria, and help the gut work better after treatment. About …
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
New study aims to catch hidden financial struggles in Alzheimer's families
Knowledge-focused Recruiting nowThis study aims to create simple screening tools to identify financial hardship in people with Alzheimer's disease and their caregivers. Researchers will interview patients and caregivers, then survey large groups to develop and test these measures. The goal is to help doctors an…
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
New study aims to keep HIV patients in care during cancer treatment
Knowledge-focused Recruiting nowThis study looks at how to help people in Zimbabwe who have both cancer and HIV stay engaged in their HIV care while they are being treated for cancer. Researchers will first observe 150 patients to understand the barriers, then develop and test strategies to overcome them with a…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC